Frederik Miggelbrink

Title: The Innovative Contributions of Frederik Miggelbrink

Introduction

Frederik Miggelbrink is a notable inventor based in Lille, France. He has made significant contributions to the field of biochemistry, particularly in the area of enzyme inactivation. His work has implications for various industries, including food processing and pharmaceuticals.

Latest Patents

Frederik Miggelbrink holds a patent for a method for the inactivation of amylase in the presence of protease. This invention involves maintaining a solution at a pH between 2.1 and 2.8 and at a temperature between 20°C and 40°C for a sufficient period to inactivate amylase by at least 95%. The method ensures that the residual aspartic protease activity remains high, at least 90%, while reducing amylase activity to 0.05 RAU/g or lower, achieving more than 99% inactivation.

Career Highlights

Miggelbrink is associated with Dsm IP Assets B.V., where he applies his expertise in enzyme technology. His innovative approach to enzyme inactivation has positioned him as a valuable asset in his field. With a focus on practical applications, he continues to contribute to advancements in biochemistry.

Collaborations

Frederik has collaborated with notable colleagues such as Mylene Caussette and Gregory Maufroid. These partnerships have fostered a collaborative environment that enhances innovation and research in enzyme technology.

Conclusion

Frederik Miggelbrink's contributions to enzyme inactivation demonstrate his commitment to innovation in biochemistry. His patent reflects a significant advancement in the field, showcasing the importance of his work.